Carol Giltner Gallagher is of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 629,608 shares of ATRA, which is worth approximately $7.68 Million. The most recent transaction as insider was on Mar 31, 2024, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 630K
0% 3M change
37.04% 12M change
Total Value Held $7.68 Million

Carol Giltner Gallagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2024
BUY
Grant, award, or other acquisition
-
150,000 Added 19.24%
629,608 Common Stock
Nov 14 2023
BUY
Open market or private purchase
$28,203 $0.31 p/Share
90,980 Added 16.53%
459,418 Common Stock
Nov 13 2023
BUY
Open market or private purchase
$39,384 $0.22 p/Share
179,020 Added 32.7%
368,438 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
57,000 Added 23.13%
189,418 Common Stock
Jun 23 2022
BUY
Grant, award, or other acquisition
-
20,500 Added 13.41%
132,418 Common Stock
Jun 08 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 8.96%
111,818 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
CERT
Certara, Inc. Healthcare
PMVP
PMV Pharmaceuticals, Inc. Healthcare
FLAC
Frazier Lifesciences Acquisition Corp Financial Services
MRTX
Mirati Therapeutics, Inc. Healthcare
CGG

Carol Giltner Gallagher

San Diego, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Track Activities on ATRA